ProShare Advisors’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

ProShare Advisors’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22,586	Closed	-$422K	–	2265
2022 Q1	$422K	Sell	22,586 -3,724	-14%	-$67K	﹤0.01%	1398
2021 Q4	$563K	Buy	26,310 +12,123	+85%	+$239K	﹤0.01%	1364
2021 Q3	$262K	Sell	14,187 -8,771	-38%	-$177K	﹤0.01%	1643
2021 Q2	$492K	Sell	22,958 -622	-3%	-$12.6K	﹤0.01%	1555
2021 Q1	$455K	Buy	+23,580	New	+$415K	﹤0.01%	1510

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ProShare Advisors's OCDX Position: Q2 2022 in Review

ProShare Advisors sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 22,586 shares — an estimated $422K sold.

ProShare Advisors first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $563K in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

ProShare Advisors reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
ProShare Advisors sold 22,586 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $422K.
ProShare Advisors first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
ProShare Advisors's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $563K in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.